Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states

View ORCID ProfilePedro C Hallal, View ORCID ProfileFernando P Hartwig, View ORCID ProfileBernardo L Horta, View ORCID ProfileGabriel D Victora, View ORCID ProfileMariângela F Silveira, View ORCID ProfileClaudio J Struchiner, View ORCID ProfileLuís Paulo Vidaleti, View ORCID ProfileNelson Arns Neumann, View ORCID ProfileLúcia C Pellanda, View ORCID ProfileOdir A Dellagostin, View ORCID ProfileMarcelo N Burattini, View ORCID ProfileAna M B Menezes, View ORCID ProfileFernando C Barros, View ORCID ProfileAluísio J D Barros, View ORCID ProfileCesar G Victora
doi: https://doi.org/10.1101/2020.05.30.20117531
Pedro C Hallal
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pedro C Hallal
  • For correspondence: prchallal@gmail.com
Fernando P Hartwig
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando P Hartwig
Bernardo L Horta
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernardo L Horta
Gabriel D Victora
3Laboratory of Lymphocyte Dynamics, Rockefeller University, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriel D Victora
Mariângela F Silveira
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mariângela F Silveira
Claudio J Struchiner
4Fundação Getúlio Vargas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claudio J Struchiner
Luís Paulo Vidaleti
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luís Paulo Vidaleti
Nelson Arns Neumann
5Pastorate of the Child, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nelson Arns Neumann
Lúcia C Pellanda
6Fundação Universidade Federal de Ciências de Saúde de Porto Alegre, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lúcia C Pellanda
Odir A Dellagostin
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Odir A Dellagostin
Marcelo N Burattini
7Universidade Federal de São Paulo, Brazil
8Universidade de São Paulo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcelo N Burattini
Ana M B Menezes
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana M B Menezes
Fernando C Barros
1Universidade Federal de Pelotas, Brazil
2Universidade Católica de Pelotas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fernando C Barros
Aluísio J D Barros
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aluísio J D Barros
Cesar G Victora
1Universidade Federal de Pelotas, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cesar G Victora
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Population based data on COVID-19 are essential for guiding public policies. We report on the first of a series of planned seroprevalence surveys relying upon on household probabilistic samples of 133 large sentinel cities in Brazil, including 25,025 participants from all 26 states and the Federal District. Seroprevalence of antibodies to SARS-CoV-2, assessed using a lateral flow rapid test, varied markedly across the country’s cities and regions, from below 1% in most cities in the South and Center-West regions to up to 25% in the city of Breves in the Amazon (North) region. Eleven of the 15 cities with the highest seroprevalence were located in the North, including the six cities with highest prevalence which were located along a 2,000 km stretch of the Amazon river. Overall seroprevalence for the 90 cities with sample size of 200 or greater was 1.4% (95% CI 1.3–1.6). Extrapolating this figure to the population of these cities, which represent 25% of the country’s population, led to an estimate of 760,000 cases, as compared to the 104,782 cases reported in official statistics. Seroprevalence did not vary significantly between infancy and age 79 years, but fell by approximately two-thirds after age 80 years. Prevalence was highest among indigenous people (3.7%) and lowest among whites (0.6%), a difference which was maintained when analyses were restricted to the North region, where most indigenous people live. Our results suggest that pandemic is highly heterogenous, with rapid escalation in Brazil’s North and Northeast, and slow progression in the South and Center-West regions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding was provided by the Brazilian Ministry of Health. We acknowledge the support from Instituto Serrapilheira, Pastoral da Crianca, the Brazilian Collective Health Association (ABRASCO) and JBS though the Fazer o Bem Faz Bem initiative.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Interviewers were tested and found to be negative for the virus, and were provided with individual protection equipment that was discarded after visiting each home. Ethical approval was obtained from the Brazilian National Ethics Committee (process number CAAE 30721520.7.1001.5313), with written informed consent from all participants. Positive cases were reported to the municipal COVID-19 surveillance systems.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • prchallal{at}gmail.com; fernandophratwig{at}gmail.com, blhorta{at}gmail.com, victora{at}rockefeller.edu, mariangelafreitassilveira{at}gmail.com, claustru{at}gmail.com, lpvidaletti{at}equidade.org, nneumann{at}pastoraldacrianca.org.br, pellanda{at}ufcspa.edu.br, odirad{at}gmail.com, mnburatt{at}gmail.com, anamene.epi{at}gmail.com, fcbarros.epi{at}gmail.com, abarros.epi{at}gmail.com, cvictora{at}gmail.com

Data Availability

Data will become publicly available upon request from the corresponding author 30 days after publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 30, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states
Pedro C Hallal, Fernando P Hartwig, Bernardo L Horta, Gabriel D Victora, Mariângela F Silveira, Claudio J Struchiner, Luís Paulo Vidaleti, Nelson Arns Neumann, Lúcia C Pellanda, Odir A Dellagostin, Marcelo N Burattini, Ana M B Menezes, Fernando C Barros, Aluísio J D Barros, Cesar G Victora
medRxiv 2020.05.30.20117531; doi: https://doi.org/10.1101/2020.05.30.20117531
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states
Pedro C Hallal, Fernando P Hartwig, Bernardo L Horta, Gabriel D Victora, Mariângela F Silveira, Claudio J Struchiner, Luís Paulo Vidaleti, Nelson Arns Neumann, Lúcia C Pellanda, Odir A Dellagostin, Marcelo N Burattini, Ana M B Menezes, Fernando C Barros, Aluísio J D Barros, Cesar G Victora
medRxiv 2020.05.30.20117531; doi: https://doi.org/10.1101/2020.05.30.20117531

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (214)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1090)
  • Dentistry and Oral Medicine (194)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (497)
  • Epidemiology (9746)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2298)
  • Geriatric Medicine (221)
  • Health Economics (461)
  • Health Informatics (1548)
  • Health Policy (729)
  • Health Systems and Quality Improvement (600)
  • Hematology (236)
  • HIV/AIDS (500)
  • Infectious Diseases (except HIV/AIDS) (11618)
  • Intensive Care and Critical Care Medicine (615)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2136)
  • Nursing (133)
  • Nutrition (332)
  • Obstetrics and Gynecology (424)
  • Occupational and Environmental Health (516)
  • Oncology (1171)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (144)
  • Palliative Medicine (50)
  • Pathology (308)
  • Pediatrics (692)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2168)
  • Public and Global Health (4640)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (450)
  • Respiratory Medicine (621)
  • Rheumatology (273)
  • Sexual and Reproductive Health (224)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (42)
  • Transplantation (120)
  • Urology (94)